US S&P 500 futures are higher by 1.44% this morning and EU markets are higher by 2% as well, following the positive news coming from US biotech company Moderna, that announced last night a successful covid-19 vaccine early trial. The news sent the US futures sharply higher with Airlines, Travel and Leisure stocks jumping on the news 8% on average. The Japanese NIKKEI closed the session up 1.6% as well. The dollar responded with a move lower as FX markets responded to the news with a move to the growth currencies, the AUD/CAD. The dollar index is at 95.88 this morning, down 0.41%. Gold is trading lower on the move out of “safe heavens”, trading at $1,808 per ounce, down 0.45% and Silver futures trade this morning at $19.71 per ounce, up 0.95%. OIL will be under pressure today, the release of US OIL Inventories and OPEC+ JMMC meetings are set to create a potentially volatile trading environment on top of the positive coronavirus vaccine news. OIL is trading higher by 1.45% this morning, at $40.87 per barrel.
CAD BOC Rate Statement and Overnight rate at 8:30am, OIL Inventories at 10:30 am, and US Beige Book at 2:00 pm are the important news on the agenda Wednesday, (all times EST).
|Global Markets 24 hours wrap-up|
|TRADE||ENTRY PRICE||POSITION||OPEN PROFIT||DATE TRIGGERED||STOP LOSS||UPDATES|
S&P 500 futures are welcoming the news from US biotech Moderna that reported last night positive results for its coronavirus vaccine trials, sending airlines and travel stocks sharply higher this morning.
OIL will be in focus for investors today following OPEC+ meetings and the release of US Inventories at 10:30 am this morning.
Warning: The information provided on this page (“the information”) is for instructional purposes only, for enhancing your general knowledge of the capital market in general and using trading methods and the technical analysis method in particular. We hereby clarify that the company, its management, staff, shareholders and agents do not hold investment advisor licenses and/or portfolio manager licenses by any applicable law, and do not pretend to advise any person on the worthiness of buying, selling, holding or investing in securities and other financial assets. The information should not be construed to be a recommendation or opinion, and any person who makes any decision based on the information – does so entirely at their own risk. Be aware that the information cannot serve in lieu of advice which accounts for specific information and needs of an individual, and that investing in securities and financial assets may cause loss. The company, its management, staff and agents may have a personal interest in issues related to the information, and may hold specific securities mentioned in the information, or similar securities. If you use the information, you waive any claim or demand against the company or anyone acting on its behalf.